InnoCare Pharma

Q: What is InnoCare Pharma's company size?

Innocare pharma has 51 - 200 people working.

Biotechnology Research

Specialities :

New drug discovery

Medicinal chemistry

Discovery biology

Cmc

Pharmacology

Revenue

501M - 1B

Total Funding

Size

51 - 200

About Us

InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. InnoCare has strong in-house innovation capabilities, holding multiple foreign and domestic patents with a rich product pipeline target liquid tumors, solid tumors, and autoimmune diseases. Our team has discovered and developed a strong pipeline. InnoCare was co-founded by Professor Shi Yigong, a world-renowned structural biologist, and Dr. Cui Jisong, an outstanding leader in the biopharmaceutical industry. We have over 1000 employees. Our core R&D staff brings rich experience from the worlds top pharmaceutical companies, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, Johnson & Johnson, Bayer, etc. We are a truly global biopharmaceutical company with sites in Beijing, Nanjing, Shanghai, and Guangzhou, Hong Kong and Unites States. On March 23, 2020, InnoCare off...

Contact Information

Beijing , Beijing , China

info@innocarepharma.com

innocarepharma.com

InnoCare Pharma Org Chart

InnoCare Pharma (HKEX: 09969; SSE: 688428)

(Biotechnology)

51 - 200

Nghia Ba

Chief Executive Officer

View Email

View Contact

View Email

View Contact

Employees

Total Employees:
49

Top Contacts:
5

C-Level 1	VP - Level-
Director-	Manager4
Others46

Employees Working At InnoCare Pharma

Nghia Ba

Chief Executive Officer

Jinling Hu

Director of Clinical Project Management

Yi Du

Director of Business Development

Leisa Chen

Director Clinical Operations

Weige Wang

Senior Medical Director

InnoCare Pharma Email Formats

Structure	Email Format
<first>.<last>@	John.Smith@innocarepharma.com

Buyer Intent

Pain Points	Locations	Technologies
Build & Release	Beijing, Beijing, China	operations, scanning, communication, assessment
Build & Release	Changsha, Hunan, China	financial, communication, integrity, data query
Build & Release	Hangzhou, Zhejiang, China
Build & Release	Nanchang, Jiangxi, China	financial, communication, integrity, data query
Build & Release	Zhengzhou, Henan, China	financial, integrity, communication, data query

Trigger

Tech Stack Used By InnoCare Pharma

A quick view of products employed by InnoCare Pharma

Gcp

Excel

Microsoft word

Visit

Word

List of technologies used by InnoCare Pharma

Assessment

Communication

Data query

Financial

Operations

Languages Used By InnoCare Pharma

Basic

OS Used By InnoCare Pharma

Integrity

Jobs at InnoCare Pharma

Hiring 2024-06-29 16:46:40

Chief of Staff(PMO)(J10072)

Beijing, Beijing, China

:Location: Beijing, ChinaReporting to: CEOJob SummaryInnoCare Pharmaceutical is seeking an except...

Hiring 2024-11-11 09:14:48

CRA(J10007)

Zhengzhou, Henan, China

::Key Objectives/Deliverables:SOPGCP,,,,,PM/(CRF),,,CRO,/Key ResponsibilitiesPerform site selecti...

Hiring 2024-12-20 20:08:22

Langfang, Hebei, China

:Key Objectives/Deliverables:;,,;;,;;HCC;:Basic Requirements,,;1;MS Office,,

Hiring 2024-12-31 13:50:05

()(J10219)

Chongqing, Chongqing, China

!:1 , ;2,,;3 ,;4,,;123,,3,4,,,5,,,

Hiring 2024-07-14 13:38:44

Nanjing, Jiangsu, China

1:1),TWestern blotting ELISA;2).,;2:1),2)2;3)::,,

Hiring 2024-12-28 21:02:09

()(J10228)

Changchun, Jilin, China

:1 , ;2,,;3 ,;4,,;:122,,3,4,,,5,,,

Hiring 2024-12-27 03:24:50

CRA(J10007)

Ürümqi County, Xinjiang Uygur, China

::Key Objectives/Deliverables:SOPGCP,,,,,PM/(CRF),,,CRO,/Key ResponsibilitiesPerform site selecti...

Hiring 2024-12-27 03:48:06

()(J10222)

Nanchang, Jiangxi, China

!:1 , ;2,,;3 ,;4,,;123,,3,4,,,5,,,

Frequently Asked Questions About InnoCare Pharma

What does Innocare pharma do?+

What are Innocare pharma's specialties? +

New drug discovery,medicinal chemistry,discovery biology,cmc,pharmacology,oncology diseases,autoimmune diseases,clinical development,medical research,and biotechnology